AZothBio

Delivery Solution Provider

Our delivery solution generates optimized peptides and LNPs to targeting cellular organelles.
We are continually improving its delivering accuracy and expending its cargo types.

Pipelines by DDiSTA

Pipeline PDF Indication Status Brief MOA

AZBT51105

T Cell Vaccine

PDF다운

Cancer Vaccine / Virus Vaccine

First-in-Class

Using immunotherapy to recognize and eliminate
cancer cells

AZBR52209

siRNA Delivery Peptide

PDF다운

RNAi Therapy

First-in-Class

Prevent disease-causing mutations of protein by targeted gene inhibition

AZBE53206

ER Targeting Peptide

PDF다운

ER Stress related Disease

First-in-Class

Intervening in ER stress and modulating signaling components of the UPR

As of 2022.Q2

Pipeline Schedule

Pipeline 2021 2022 2023 2024
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q
AZBT51105

In vitro

In vivo

Pre-clinical

License out

AZBR52209

Target analysis

In vitro

In vivo

Pre-clinical

License out

AZBE53206

Target analysis

In vitro

In vivo

Pre-clinical

License out

DDiSTA Based Solution

- Prediction of CPP sequence and LNPs for Efficient Drug Delivery into Specific Organelles

In silico

  • Step 1
    Sequencing Profiling
    Sequence & Structure
    Propensity Score
    Optimization
  • Step 2
    Screening
    3D Structure
    Properties and Stability
    Overall score

In vitro & In vivo

  • Step 3
    POC Verification
    In-House Lab Assay
    CRO & Research Partners
위로